The American Journal of Psychiatry
Journal Home Search Current Issue Past Issues Subscribe All APPI Journals Help Contact Us
 
Quicksearch
Advanced Search
Or Search All APPI Journals
This Article
* Full Text
* Full Text (PDF)
* Alert me when this article is cited
* Alert me if a correction is posted
* Citation Map
Services
* Email this article to a Colleague
* Similar articles in this journal
* Similar articles in PubMed
* Alert me to new issues of the journal
* Add to My Articles & Searches
* Download to citation manager
* reprints & permissions
Citing Articles
* Citing Articles via HighWire
* Citing Articles via Google Scholar
Google Scholar
* Articles by Sanacora, G.
* Articles by Krystal, J. H.
* Search for Related Content
PubMed
* PubMed Citation
* Articles by Sanacora, G.
* Articles by Krystal, J. H.
Related Collections
* Neuroendocrinology
* ECT
Am J Psychiatry 160:577-579, March 2003
© 2003 American Psychiatric Association


Brief Report

Increased Cortical GABA Concentrations in Depressed Patients Receiving ECT

Gerard Sanacora, M.D., Ph.D., Graeme F. Mason, Ph.D., Douglas L. Rothman, Ph.D., Fahmeed Hyder, M.D., James J. Ciarcia, M.D., Robert B. Ostroff, M.D., Robert M. Berman, M.D., and John H. Krystal, M.D.

OBJECTIVE: Reduced {gamma}-aminobutyric acid (GABA) concentrations have been reported in the plasma, CSF, and cortex of depressed subjects. Of interest is that ECT, one of the most effective treatments for severe refractory depression, produces considerable anticonvulsant effects that may be related to increased GABAergic transmission. The purpose of this study was to determine if cortical GABA concentrations increase following a course of ECT. METHOD: Occipital cortex GABA concentrations in eight depressed patients were measured by using proton magnetic resonance spectroscopy before and after a course of ECT. RESULTS: A significant increase in occipital cortex GABA concentrations was seen following ECT treatment of depression. CONCLUSIONS: Occipital cortex GABA concentrations increase two-fold following ECT. This suggests possible GABAergic involvement in ECT’s mechanism of anticonvulsant and antidepressant actions.




This article has been cited by other articles:


Home page
NEJMHome page
J. C. Huffman, L. T. Park, C. A. Welch, A. A. Nierenberg, J. L. Januzzi Jr., and S. R. Pomerantz
Case 14-2008 -- A 78-Year-Old Man with Anergia and Anhedonia Associated with Cardiovascular Surgery
N. Engl. J. Med., May 8, 2008; 358(19): 2051 - 2059.
[Full Text] [PDF]


Home page
NEJMHome page
S. H. Lisanby
Electroconvulsive Therapy for Depression
N. Engl. J. Med., November 8, 2007; 357(19): 1939 - 1945.
[Full Text] [PDF]


Home page
J. Neurosci.Home page
T. D. Perera, J. D. Coplan, S. H. Lisanby, C. M. Lipira, M. Arif, C. Carpio, G. Spitzer, L. Santarelli, B. Scharf, R. Hen, et al.
Antidepressant-Induced Neurogenesis in the Hippocampus of Adult Nonhuman Primates
J. Neurosci., May 2, 2007; 27(18): 4894 - 4901.
[Abstract] [Full Text] [PDF]


Home page
Arch Gen PsychiatryHome page
G. Hasler, J. W. van der Veen, T. Tumonis, N. Meyers, J. Shen, and W. C. Drevets
Reduced Prefrontal Glutamate/Glutamine and {gamma}-Aminobutyric Acid Levels in Major Depression Determined Using Proton Magnetic Resonance Spectroscopy
Arch Gen Psychiatry, February 1, 2007; 64(2): 193 - 200.
[Abstract] [Full Text] [PDF]


Home page
Am. J. PsychiatryHome page
M. BAJBOUJ, U. E. LANG, P. NEU, and I. HEUSER
Therapeutic Brain Stimulation and Cortical Excitability in Depressed Patients
Am J Psychiatry, November 1, 2005; 162(11): 2192 - 2193.
[Full Text] [PDF]


Home page
Arch Gen PsychiatryHome page
G. Sanacora, R. Gueorguieva, C. N. Epperson, Y.-T. Wu, M. Appel, D. L. Rothman, J. H. Krystal, and G. F. Mason
Subtype-Specific Alterations of {gamma}-Aminobutyric Acid and Glutamate in Patients With Major Depression
Arch Gen Psychiatry, July 1, 2004; 61(7): 705 - 713.
[Abstract] [Full Text] [PDF]


Home page
Am. J. PsychiatryHome page
Z. Bhagwagar, M. Wylezinska, M. Taylor, P. Jezzard, P. M. Matthews, and P. J. Cowen
Increased Brain GABA Concentrations Following Acute Administration of a Selective Serotonin Reuptake Inhibitor
Am J Psychiatry, February 1, 2004; 161(2): 368 - 370.
[Abstract] [Full Text] [PDF]


Home page
Ann. N. Y. Acad. Sci.Home page
G. SANACORA, D. L. ROTHMAN, G. MASON, and J. H. KRYSTAL
Clinical Studies Implementing Glutamate Neurotransmission in Mood Disorders
Ann. N.Y. Acad. Sci., November 1, 2003; 1003(1): 292 - 308.
[Abstract] [Full Text] [PDF]




Get information about faster international access.

Privacy Policy

Copyright © 2003 American Psychiatric Association. All rights reserved.

Home | Search | Current Issue | Past Issues | Subscribe | All APPI Journals | Help | Contact Us

American Psychiatric Publishing, Inc. American Psychiatric Association
1000 Wilson Boulevard, Suite 1825, Arlington, VA 22209-3901 * 800-368-5777 * appi at psych.org